{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:00:19Z","timestamp":1792202419058,"version":"4.4.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2021-01-50"],"award-info":[{"award-number":["320.6750.2021-01-50"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.tranon.2023.101640","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T11:56:16Z","timestamp":1676116576000},"page":"101640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Nuclear protein in testis carcinoma of the lung"],"prefix":"10.1016","volume":"30","author":[{"given":"Jing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0404-5153","authenticated-orcid":false,"given":"Hongyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tranon.2023.101640_bib0001","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrc3659","article-title":"NUT midline carcinoma","volume":"14","author":"French","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2023.101640_bib0002","first-page":"3632","article-title":"Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck","volume":"122","author":"Chau","year":"2016","journal-title":"CANCER-AM Cancer Soc."},{"issue":"4","key":"10.1016\/j.tranon.2023.101640_bib0003","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00043426-199124000-00011","article-title":"Intrathoracic carcinoma in an 11-year-old girl showing a translocation T (15;19)","volume":"13","author":"Kees","year":"1991","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2023.101640_bib0004","first-page":"3327","article-title":"Novel T (15;19) (Q15; P13) chromosome abnormality in a thymic carcinoma","volume":"51","author":"Kubonishi","year":"1991","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.tranon.2023.101640_bib0005","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/pbc.20755","article-title":"Successful treatment of a child with T (15;19)-positive tumor","volume":"49","author":"Mertens","year":"2007","journal-title":"Pediatr. Blood. Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2023.101640_bib0006","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12105-010-0174-6","article-title":"NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland","volume":"4","author":"Ziai","year":"2010","journal-title":"Head Neck Pathol."},{"issue":"6","key":"10.1016\/j.tranon.2023.101640_bib0007","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2350\/09-10-0727-CR.1","article-title":"NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic\/hepatic primary","volume":"13","author":"Shehata","year":"2010","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.tranon.2023.101640_bib0008","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/PAS.0000000000001046","article-title":"NUT carcinoma of the salivary glands: clinicopathologic and molecular analysis of 3 cases and a survey of NUT expression in salivary gland carcinomas","volume":"42","author":"Agaimy","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"issue":"15","key":"10.1016\/j.tranon.2023.101640_bib0009","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/sj.onc.1210852","article-title":"BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells","volume":"27","author":"French","year":"2008","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.tranon.2023.101640_bib0010","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/2159-8290.CD-14-0014","article-title":"NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism","volume":"4","author":"French","year":"2014","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.tranon.2023.101640_bib0011","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/PAS.0000000000001774","article-title":"Misleading germ cell phenotype in pulmonary NUT carcinoma harboring the ZNF532-NUTM1 fusion","volume":"46","author":"Agaimy","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"issue":"11","key":"10.1016\/j.tranon.2023.101640_bib0012","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/gcc.22785","article-title":"Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family","volume":"58","author":"Chien","year":"2019","journal-title":"Gene. Chromosome. Cancer"},{"issue":"21","key":"10.1016\/j.tranon.2023.101640_bib0013","doi-asserted-by":"crossref","first-page":"E4184","DOI":"10.1073\/pnas.1702086114","article-title":"Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma","volume":"114","author":"Alekseyenko","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.tranon.2023.101640_bib0014","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1158\/1541-7786.MCR-18-0474","article-title":"Z4\" complex member fusions in NUT carcinoma: implications for a novel oncogenic mechanism","volume":"16","author":"Shiota","year":"2018","journal-title":"Mol. Cancer Res."},{"issue":"9","key":"10.1016\/j.tranon.2023.101640_bib0015","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/gcc.3","article-title":"CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies","volume":"57","author":"Schaefer","year":"2018","journal-title":"Gene. Chromosome. Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2023.101640_bib0016","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a003194","article-title":"A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma","volume":"4","author":"Diolaiti","year":"2018","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"10.1016\/j.tranon.2023.101640_bib0017","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00428-019-02623-8","article-title":"Sarcoma with MGA-NUTM1 fusion in the lung: an emerging entity","volume":"476","author":"Taichiro","year":"2020","journal-title":"Virchows. Arch."},{"issue":"13","key":"10.1016\/j.tranon.2023.101640_bib0018","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.celrep.2018.08.069","article-title":"Nut directs p300-dependent, genome-wide H4 hyperacetylation in male germ cells","volume":"24","author":"Shiota","year":"2018","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.tranon.2023.101640_bib0019","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.semdp.2021.06.005","article-title":"NUT carcinoma of the lung","volume":"38","author":"Lantuejoul","year":"2021","journal-title":"Semin. Diagn. Pathol."},{"issue":"15","key":"10.1016\/j.tranon.2023.101640_bib0020","doi-asserted-by":"crossref","first-page":"8758","DOI":"10.1073\/pnas.1433065100","article-title":"The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis","volume":"100","author":"Dey","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.tranon.2023.101640_bib0021","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/s41388-020-01625-0","article-title":"Supercharging BRD4 with NUT in carcinoma","volume":"40","author":"Eagen","year":"2021","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.tranon.2023.101640_bib0022","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1158\/0008-5472.CAN-13-2658","article-title":"Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma","volume":"74","author":"Wang","year":"2014","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.tranon.2023.101640_bib0023","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/onc.2013.126","article-title":"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma","volume":"33","author":"Grayson","year":"2014","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.tranon.2023.101640_bib0024","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1101\/gad.267583.115","article-title":"The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains","volume":"29","author":"Alekseyenko","year":"2015","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.tranon.2023.101640_bib0025","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00405-018-4882-y","article-title":"Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases","volume":"275","author":"Giridhar","year":"2018","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"20","key":"10.1016\/j.tranon.2023.101640_bib0026","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1200\/JCO.2004.02.107","article-title":"Midline carcinoma of children and young adults with NUT rearrangement","volume":"22","author":"French","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2023.101640_bib0027","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/PAS.0000000000001021","article-title":"NUTM1 gene fusions characterize a subset of undifferentiated soft tissue and visceral tumors","volume":"42","author":"Dickson","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"issue":"23","key":"10.1016\/j.tranon.2023.101640_bib0028","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1002\/cncr.30242","article-title":"Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck","volume":"122","author":"Chau","year":"2016","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.tranon.2023.101640_bib0029","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.3390\/curroncol29100536","article-title":"Treatment and prognosis of primary pulmonary NUT carcinoma. A literature review","volume":"29","author":"Yuan","year":"2022","journal-title":"Curr. Oncol."},{"issue":"11","key":"10.1016\/j.tranon.2023.101640_bib0030","first-page":"1040","article-title":"Clinical diagnosis and treatment of primary lung NUT midline carcinoma","volume":"46","author":"He","year":"2019","journal-title":"Cancer Res. Prev. Treat."},{"issue":"6","key":"10.1016\/j.tranon.2023.101640_bib0031","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/JTO.0000000000000545","article-title":"Primary pulmonary NUT midline carcinoma: Clinical, radiographic, and pathologic characterizations","volume":"10","author":"Sholl","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2023.101640_bib0032","doi-asserted-by":"crossref","first-page":"W391","DOI":"10.2214\/AJR.13.12401","article-title":"Demystifying NUT midline carcinoma: radiologic and pathologic correlations of an aggressive malignancy","volume":"203","author":"Bair","year":"2014","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.tranon.2023.101640_bib0033","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13023-020-01449-x","article-title":"Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma","volume":"15","author":"Xie","year":"2020","journal-title":"Orphanet. J. Rare. Dis."},{"issue":"07","key":"10.1016\/j.tranon.2023.101640_bib0034","first-page":"1078","article-title":"A case report of primary pulmonary NUT midline carcinoma in children","volume":"40","author":"Zhang","year":"2020","journal-title":"J. Nanjing Med. Univ. (Nat. Sci. Ed.)"},{"issue":"05","key":"10.1016\/j.tranon.2023.101640_bib0035","first-page":"350","article-title":"Observation of clinical pathology in three cases of Pulmonary NUT carcinoma","volume":"24","author":"Huang","year":"2017","journal-title":"J. Diagnost. Pathol."},{"issue":"2","key":"10.1016\/j.tranon.2023.101640_bib0036","article-title":"NUT midline lung cancer: a rare case report with literature review","volume":"6","author":"Gupta","year":"2022","journal-title":"AME Case Rep."},{"issue":"1","key":"10.1016\/j.tranon.2023.101640_bib0037","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13000-021-01188-y","article-title":"NUT midline carcinoma as a primary lung tumor treated with anlotinib combined with palliative radiotherapy: a case report","volume":"17","author":"Jiang","year":"2022","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.tranon.2023.101640_bib0038","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/PAS.0b013e31824230a8","article-title":"NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin","volume":"36","author":"Mio","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"12","key":"10.1016\/j.tranon.2023.101640_bib0039","doi-asserted-by":"crossref","first-page":"E1045","DOI":"10.21037\/jtd.2017.11.50","article-title":"NUT midline carcinoma as a primary lung tumor: a case report","volume":"9","author":"Cao","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.tranon.2023.101640_bib0040","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1111\/1759-7714.13648","article-title":"Clinicopathological characteristics of primary lung nuclear protein in testis carcinoma: a single-institute experience of 10 cases","volume":"11","author":"Cho","year":"2020","journal-title":"Thorac. Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2023.101640_bib0041","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jcp.2007.052902","article-title":"Demystified molecular pathology of NUT midline carcinomas","volume":"63","author":"French","year":"2010","journal-title":"J. Clin. Pathol."},{"issue":"8","key":"10.1016\/j.tranon.2023.101640_bib0042","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/PAS.0b013e3181abe120","article-title":"NUT midline carcinoma of the parotid gland with mesenchymal differentiation","volume":"33","author":"Den Bakker","year":"2009","journal-title":"Am. J. SurgPathol"},{"issue":"20","key":"10.1016\/j.tranon.2023.101640_bib0043","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1158\/1078-0432.CCR-12-1153","article-title":"Clinicopathologic features and long-term outcomes of NUT midline carcinoma","volume":"18","author":"Bauer","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.tranon.2023.101640_bib0044","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/his.13143","article-title":"NUT midline carcinoma of the larynx: an international series and review of the literature","volume":"70","author":"Hellquist","year":"2017","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.tranon.2023.101640_bib0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1066896915606970","article-title":"The gross appearance of a NUT midline carcinoma","volume":"24","author":"Wasserman","year":"2016","journal-title":"Int. J. Surg. Pathol."},{"issue":"11","key":"10.1016\/j.tranon.2023.101640_bib0046","first-page":"1415","article-title":"CT manifestations of lung NUT cancer","volume":"35","author":"Zhang","year":"2020","journal-title":"Radiolog. Pract."},{"issue":"8","key":"10.1016\/j.tranon.2023.101640_bib0047","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1097\/MPH.0000000000000082","article-title":"A case of NUT midline carcinoma with complete response to gemcitabine following cisplatin and docetaxel","volume":"36","author":"Ueki","year":"2014","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2023.101640_bib0048","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.arbr.2016.04.014","article-title":"NUT midline carcinoma of the lung,a rare form of lung cancer","volume":"52","author":"Benito Bernaldez","year":"2016","journal-title":"Arch. Bronconeumol."},{"issue":"9","key":"10.1016\/j.tranon.2023.101640_bib0049","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/dc.23291","article-title":"Cytologic findings of NUT midline carcinoma in the hilum of the lung","volume":"43","author":"Policarpio-Nicolas","year":"2015","journal-title":"Diagn. Cytopathol."},{"issue":"10","key":"10.1016\/j.tranon.2023.101640_bib0050","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/JTO.0b013e3182a00f41","article-title":"NUT midline carcinoma: an aggressive intrathoracic neoplasm","volume":"8","author":"Parikh","year":"2013","journal-title":"J. Thorac. Oncol."},{"issue":"15","key":"10.1016\/j.tranon.2023.101640_bib0051","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1200\/JCO.2012.48.5300","article-title":"Nuclear Protein in testis midline carcinoma misdiagnosed as adamantinoma","volume":"32","author":"Puliyel","year":"2014","journal-title":"J. ClinOncol."},{"issue":"2","key":"10.1016\/j.tranon.2023.101640_bib0052","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1066896918796606","article-title":"NUT (Nuclear Protein in Testis) carcinoma: a report of two cases with different histopathologic features","volume":"27","author":"Reddy","year":"2019","journal-title":"Int. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.tranon.2023.101640_bib0053","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.lungcan.2015.10.001","article-title":"NUT carcinoma of the thorax: case report and review of the literature","volume":"90","author":"Harms","year":"2015","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2023.101640_bib0054","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/15513815.2017.1392662","article-title":"NUT midline carcinoma of the lung in a six-year-old child","volume":"36","author":"Karakus","year":"2017","journal-title":"Fetal. Pediatr. Pathol."},{"issue":"7","key":"10.1016\/j.tranon.2023.101640_bib0055","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/PAS.0b013e318198d666","article-title":"Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody","volume":"33","author":"Haack","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.tranon.2023.101640_bib0056","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/dc.24150","article-title":"Midline carcinoma expressing NUT in malignant effusion cytology","volume":"47","author":"Shenoy","year":"2019","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.tranon.2023.101640_bib0057","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cncy.22342","article-title":"Cytomorphology of primary pulmonary NUT carcinoma in different cytology preparations","volume":"129","author":"Dutta","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.tranon.2023.101640_bib0058","first-page":"1","article-title":"Clinicopathological analysis of five cases of NUT midline carcinoma, including one with the Gingiva","volume":"2020","author":"Zhou","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.tranon.2023.101640_bib0059","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1053\/j.semdp.2021.06.001","article-title":"Recent updates in thoracic SMARCA4-deficient undifferentiated tumor","volume":"38","author":"Nambirajan","year":"2021","journal-title":"Semin. Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.tranon.2023.101640_bib0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00428-020-03011-3","article-title":"Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors","volume":"478","author":"Chatzopoulos","year":"2021","journal-title":"Virchows. Arch."},{"issue":"15","key":"10.1016\/j.tranon.2023.101640_bib0061","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/1759-7714.14547","article-title":"SMARCA4-deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: a case report","volume":"13","author":"Utsumi","year":"2022","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.tranon.2023.101640_bib0062","first-page":"z94","article-title":"An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients","volume":"4","author":"Chau","year":"2020","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.tranon.2023.101640_bib0063","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2147\/OTT.S173056","article-title":"NUT midline carcinoma of the head and neck: current perspectives","volume":"12","author":"Napolitano","year":"2019","journal-title":"Onco. Target. Ther."},{"key":"10.1016\/j.tranon.2023.101640_bib0064","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/2159-8290.CD-15-1335","article-title":"Clinical response of carcinomas harboring the brd4-nut oncoprotein to the targeted bromodomain inhibitor OTX015\/MK-8628","volume":"6","author":"Stathis","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tranon.2023.101640_bib0065","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.1634\/theoncologist.2018-0477","article-title":"Clinicopathological and preclinical findings of NUT carcinoma: a multicenter study","volume":"24","author":"Jung","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.tranon.2023.101640_bib0066","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/1535-7163.MCT-16-0390","article-title":"Dual HDAC and PI3K inhibitor CUDC-907 downregulates MYC and suppresses growth of MYC-dependent cancers","volume":"16","author":"Sun","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tranon.2023.101640_bib0067","first-page":"451","article-title":"Prolonged disease stabilization and tolerability in a nuclear protein in testis midline carcinoma patient treated with dual histone deacetylase and phosphoinositide 3-kinase inhibitor CUDC-907","volume":"7","author":"Munster","year":"2018","journal-title":"Case Rep. Clin. Med."},{"key":"10.1016\/j.tranon.2023.101640_bib0068","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1158\/1535-7163.MCT-20-0087","article-title":"Combined targeting of the BRD4\u2013NUT\u2013P300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734","volume":"19","author":"Morrison-Smith","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tranon.2023.101640_bib0069","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/2159-8290.CD-17-0605","article-title":"BET proteins as targets for anticancer treatment","volume":"8","author":"Stathis","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tranon.2023.101640_bib0070","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1038\/s41388-020-1301-9","article-title":"Therapeutic targeting of P300\/CBP HAT domain for the treatment of NUT midline carcinoma","volume":"39","author":"Zhang","year":"2020","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.tranon.2023.101640_bib0071","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.celrep.2017.02.011","article-title":"BET-bromodomain inhibitors engage the host immune system and regulate expression of the immune checkpoint ligand PD-L1","volume":"18","author":"Hogg","year":"2017","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.tranon.2023.101640_bib0072","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1172\/JCI86437","article-title":"BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models","volume":"126","author":"Kagoya","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tranon.2023.101640_bib0073","doi-asserted-by":"crossref","first-page":"CT014","DOI":"10.1158\/1538-7445.AM2016-CT014","article-title":"Abstract CT014: GSK525762, a selective bromodomain (BRD) and extra terminal protein (BET) inhibitor: results from part 1 of a phase I\/II open-label single-agent study in patients with NUT midline carcinoma (NMC) and other cancers","volume":"76","author":"O'Dwyer","year":"2016","journal-title":"Cancer Res."},{"issue":"30","key":"10.1016\/j.tranon.2023.101640_bib0074","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2018.78.2292","article-title":"Phase Ib trial with birabresib, a small-molecule inhibitor of bromodomain and extraterminal proteins, in patients with selected advanced solid tumors","volume":"36","author":"Lewin","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2023.101640_bib0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/pbc.25350","article-title":"Histone deacetylase inhibitor for NUT midline carcinoma","volume":"62","author":"Maher","year":"2015","journal-title":"Pediatr. Blood. Cancer"},{"issue":"7","key":"10.1016\/j.tranon.2023.101640_bib0076","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1158\/0008-5472.CAN-10-3513","article-title":"Differentiation of NUT midline carcinoma by epigenomic reprogramming","volume":"71","author":"Schwartz","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2023.101640_bib0077","doi-asserted-by":"crossref","first-page":"424","DOI":"10.12659\/AJCR.893879","article-title":"Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma","volume":"16","author":"Maur","year":"2015","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.tranon.2023.101640_bib0078","unstructured":"ClinicalTrials.gov. Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer (2019). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03936465."},{"key":"10.1016\/j.tranon.2023.101640_bib0079","article-title":"Immunotherapy and targeting the tumor microenvironment: current place and new insights in primary pulmonary NUT carcinoma","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2023.101640_bib0080","doi-asserted-by":"crossref","first-page":"860830","DOI":"10.3389\/fonc.2022.860830","article-title":"NUT carcinoma: clinicopathologic features, molecular genetics and epigenetics","volume":"12","author":"Moreno","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.tranon.2023.101640_bib0081","doi-asserted-by":"crossref","first-page":"24","DOI":"10.21037\/acr-19-168","article-title":"The primary pulmonary NUT carcinomas and some uncommon somatic mutations identified by next-generation sequencing: a case report","volume":"4","author":"Liu","year":"2020","journal-title":"AME Case Rep"},{"key":"10.1016\/j.tranon.2023.101640_bib0082","first-page":"495","article-title":"Tumor mutation burden and checkpoint immunotherapy markers in NUT midline carcinoma","volume":"28","author":"He","year":"2020","journal-title":"Appl. Immunohisto. M M"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523323000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523323000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:24:31Z","timestamp":1761845071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523323000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":82,"alternative-id":["S1936523323000268"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2023.101640","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuclear protein in testis carcinoma of the lung","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2023.101640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101640"}}